igv-001
imvax
['igv-001']
imvax presents new data at aacr 2023 supporting the mechanism of action of its lead program, igv-001, for glioblastoma. more info: $xbi $ibb $xph $pph
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT